Capital World Investors
RPRX icon

Capital World Investors’s Royalty Pharma RPRX Stock Holding History

Capital World Investors’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$534M Buy
9,517,337
+1,480,623
+18% +$77.1M 0.06% 217
2026
Q1 		$386M Buy
+8,036,714
New +$352M 0.05% 230

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CIA
Caledonia Investments (Australia) Sydney NSW, Australia $2.93B AUM 37.21% 1-Year Est. Return

Capital World Investors's RPRX Position: Q2 2026 in Review

Capital World Investors increased its Royalty Pharma (RPRX) stake by 18% in Q2 2026, buying an estimated $77.1M and bringing the position to 9,517,337 shares worth $534M. The position accounts for 0.06% of the portfolio, ranked #217.

Capital World Investors first reported a position in RPRX in Q1 2026 and has held it in 2 quarters since. 642 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • Capital World Investors held 9,517,337 shares of Royalty Pharma worth $534M as of Q2 2026.
  • Capital World Investors bought 1,480,623 Royalty Pharma shares in Q2 2026, an estimated $77.1M.
  • Royalty Pharma made up 0.06% of Capital World Investors's portfolio in Q2 2026, its #217 holding.
  • Capital World Investors first reported a position in Royalty Pharma in Q1 2026 and has held it in 2 quarters since.
  • 642 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Capital World Investors's 13F filing for Q2 2026, filed 12 Aug 2026.